GENE ONLINE|News &
Opinion
Blog

Zepbound
News Flash
Comparative Analysis of Tirzepatide (Zepbound/Mounjaro) and Semaglutide (Wegovy) for Weight Loss
2025-05-12
ZepboundEli Lilly
Lilly Slashes Zepbound Vial Prices by Up to 50% to Expand Access for Uninsured Patients
2025-02-26
Obstructive Sleep Apnea
Eli Lilly’s Zepbound Becomes First and Only FDA Approved Weight Loss Drug to Treat Obstructive Sleep Apnea
2024-12-23
Market
Eli Lilly Breaks Records with $9B Total Investment in Indiana Weight-loss Drug Expansion
2024-05-27
LATEST
Pittsburgh Steelers Select Priority Technology Holdings to Manage Ticketing Payments and Treasury Operations
2026-07-14
Suja Organic Partners With Ashley Iaconetti for Summer of Loves Campaign
2026-07-14
Tempus Realty Partners Acquires $42 Million in Arkansas Commercial Real Estate
2026-07-14
Tempo Launches Cook Never Club to Reduce Meal Preparation Time for Millennials and Gen Z
2026-07-14
Danielle Fishel and Lance Bass Named QVC Co-Chief Cheer Officers for Christmas in July Event
2026-07-14
Plato’s Closet Launches In-Store Style Simulator for Back-to-School Campaign
2026-07-14
Cheer Holding Launches Klon AI Platform for Digital Portrait Generation
2026-07-14
READ MORE
EVENT
2026-07-15
BIO Asia-Taiwan 2026 (APAC Biotech & Investment)
Taipei, Taiwan
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
SEE MORE
Scroll to Top